AM-1172

From Food & Medicine Encyclopedia

AM-1172

AM-1172 is a synthetic cannabinoid that has been studied for its potential effects on the endocannabinoid system. It is part of a class of compounds that interact with the cannabinoid receptors, which are part of the G protein-coupled receptor family. These receptors are primarily found in the central nervous system and immune system, and they play a role in various physiological processes including pain sensation, mood, and memory.

Chemical Structure and Properties[edit]

AM-1172 is chemically classified as a cannabinoid and is structurally related to other synthetic cannabinoids. It is designed to mimic the effects of naturally occurring cannabinoids such as tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. The chemical structure of AM-1172 includes a core indole or indazole structure, which is common among synthetic cannabinoids.

Pharmacology[edit]

AM-1172 acts as an agonist at the CB1 receptor and CB2 receptor, which are the primary receptors for cannabinoids in the human body. The CB1 receptor is predominantly located in the brain and is responsible for the psychoactive effects of cannabinoids, while the CB2 receptor is more commonly found in the peripheral tissues and is associated with immune modulation.

Mechanism of Action[edit]

The mechanism of action of AM-1172 involves binding to the cannabinoid receptors, leading to the activation of intracellular signaling pathways. This activation can result in various effects, such as analgesia, anti-inflammatory effects, and alterations in mood and perception.

Potential Applications[edit]

Research into AM-1172 and similar compounds is ongoing, with potential applications in the treatment of conditions such as chronic pain, multiple sclerosis, and epilepsy. However, due to the psychoactive nature of these compounds, there are significant regulatory and safety concerns that must be addressed.

Legal Status[edit]

The legal status of AM-1172 varies by country. In many jurisdictions, synthetic cannabinoids are controlled substances due to their potential for abuse and lack of medical approval. Researchers must obtain special licenses to study these compounds.

Safety and Toxicology[edit]

The safety profile of AM-1172 is not well-established, and like many synthetic cannabinoids, it may pose risks of toxicity and adverse effects. These can include cardiovascular effects, psychological disturbances, and potential for addiction.

Research and Development[edit]

Ongoing research is focused on understanding the pharmacokinetics, pharmacodynamics, and therapeutic potential of AM-1172. Studies are also exploring the development of analogs with improved safety profiles and therapeutic efficacy.

Also see[edit]



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.